Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$57.26
+0.3%		$49.38
$38.91
▼
$147.03
$1.66B0.7812,298 shs394,909 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$22.72
$17.39
$10.25
▼
$29.65
$1.58B1.532.22 million shs1.69 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%-4.77%+13.32%+37.00%-34.69%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%+1.52%+33.02%+67.92%+109.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$57.26
+0.3%		$49.38
$38.91
▼
$147.03
$1.66B0.7812,298 shs394,909 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$22.72
$17.39
$10.25
▼
$29.65
$1.58B1.532.22 million shs1.69 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%-4.77%+13.32%+37.00%-34.69%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%+1.52%+33.02%+67.92%+109.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.11
Hold$66.1915.60% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.45
Hold$28.9827.53% Upside

Current Analyst Ratings Breakdown

Latest TNDM and INSP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$30.00 ➝ $26.00
8/7/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$40.00
8/7/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$17.00 ➝ $21.00
8/7/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Weight
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$54.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$54.00 ➝ $62.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$75.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$55.00 ➝ $60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$54.00 ➝ $60.00
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.82$2.87 per share19.94$26.88 per share2.13
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.01B1.56N/AN/A$2.29 per share9.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.6212.3937.674.3415.03%8.64%7.45%11/2/2026 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$0.93N/A206.55N/A-6.08%-45.97%-6.23%11/5/2026 (Estimated)

Latest TNDM and INSP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.3207-$0.31+$0.0107-$0.31$254.99 million$254.56 million
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2359$0.14+$0.3759$0.01$194.72 million$200.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
8.55
6.16
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.62
3.18
2.65

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.91 million28.27 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50069.58 million68.12 millionOptionable

Recent News About These Companies

Assenagon Asset Management S.A. Decreases Stock Position in Tandem Diabetes Care, Inc. $TNDM
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-decreases-stock-position-in-tandem-diabetes-care-inc-tndm-2026-08-17/
Tandem Diabetes Care (TNDM) Receives a Buy from Lake Street
August 16 at 8:38 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/3736543/tandem-diabetes-care-tndm-receives-a-buy-from-lake-street/
Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM
August 15 at 4:47 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-purchases-new-position-in-tandem-diabetes-care-inc-tndm-2026-08-15/
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving Average - Time to Sell?
August 15 at 2:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-nasdaqtndm-shares-cross-above-200-day-moving-average-time-to-sell-2026-08-15/
Oppenheimer Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
August 14 at 12:58 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/3736065/oppenheimer-sticks-to-its-buy-rating-for-tandem-diabetes-care-tndm/
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973318/tndm-q2-loss-narrower-than-expected-revenues-miss-stock-up?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-2973318
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
August 12, 2026  |  tipranks.comhttps://www.tipranks.com/news/ratings/tandem-diabetes-care-buy-rating-reaffirmed-on-transformation-momentum-and-innovation-catalysts-40-price-target-maintained-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Tandem Diabetes Care Earnings Call Highlights Growth
August 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/tandem-diabetes-care-earnings-call-highlights-growth?utm_source=marketbeat.com&utm_medium=referral
Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-nasdaqtndm-announces-earnings-results-beats-estimates-by-001-eps-2026-08-07/
Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933363-tandem-diabetes-care-inc-2026-q2-results-earnings-call-presentation
Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4932966-tandem-diabetes-care-inc-tndm-q2-2026-earnings-call-transcript
Tandem Diabetes Care Q2 Earnings Call Highlights
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-q2-earnings-call-highlights-2026-08-07/
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down - What's Next?
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-nasdaqtndm-shares-gap-down-whats-next-2026-08-07/
Analyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
August 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-tandem-citing-building-momentum-ahead-of-mobi-tubeless-launch-and-improving-margins-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 earnings results: Revenue in line with expectations
August 6, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/tandem-diabetes-s-nasdaq-tndm-q2-cy2026-earnings-results-revenue-in-line-with-expectations/ar-AA29yddA
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates
August 6, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970509/tandem-diabetes-care-inc-tndm-reports-q2-loss-lags-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2970509
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say
August 6, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970477/tandem-diabetes-care-tndm-reports-q2-earnings-what-key-metrics-have-to-say?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm-2970477
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results
August 6, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260806666275/en/tandem-diabetes-care-announces-second-quarter-2026-financial-results/
Quantinno Capital Management LP Has $12.54 Million Position in Tandem Diabetes Care, Inc. $TNDM
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-has-1254-million-position-in-tandem-diabetes-care-inc-tndm-2026-08-04/
Arrowstreet Capital Limited Partnership Raises Stake in Tandem Diabetes Care, Inc. $TNDM
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-arrowstreet-capital-limited-partnership-raises-stake-in-tandem-diabetes-care-inc-tndm-2026-08-04/
Tandem Diabetes Care Target of Unusually High Options Trading (NASDAQ:TNDM)
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-target-of-unusually-high-options-trading-nasdaqtndm-2026-08-03/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$57.26 +0.16 (+0.27%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$57.10 -0.15 (-0.26%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$22.72 0.00 (0.00%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$23.02 +0.30 (+1.32%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas